Andrew Faughnan | executive |
Bradley Campbell | executive |
Sebastien Martel | executive |
Jeffrey Castelli | executive |
Daphne Quimi | executive |
Tazeen Ahmad | analyst |
Anupam Rama | analyst |
Ritu Baral | analyst |
Eliana Merle | analyst |
Joseph Schwartz | analyst |
Dae Gon Ha | analyst |
Lee Hung | analyst |
Kristen Kluska | analyst |
Ethan Markowski | analyst |
Good morning, ladies and gentlemen and welcome to the Amicus Therapeutics Second Quarter 2023 Financial Results Conference Call and webcast. [Operator Instructions] As a reminder, this conference is being recorded.I would now like to turn the conference over to your host, Mr. Andrew Faughnan, Vice President of Investor Relations.
You may begin.
Thank you, Tana.